The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial

Aim. To evaluate the clinical efficacy and safety of Dietressa at a dose of 6 tablets per day for 24 weeks in the treatment of patients with Class 1 obesity. To compare the clinical efficacy of two treatment regimens (1 tablet 6 times per day and 2 tablets 3 times per day) for 24 weeks in the treatm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatiana Y. Demidova, Elena I. Krasil’nikova, Sergey V. Vorob’ev, Tatiana V. Morugova, Tatiana V. Adasheva
Formato: article
Lenguaje:RU
Publicado: "Consilium Medicum" Publishing house 2021
Materias:
R
Acceso en línea:https://doaj.org/article/dcf0ff956e4d49f68ae5f3edce4a3cd0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!